- Home
- EML vs ME Comparison
EML vs ME Comparison
Compare EML & ME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- ME
- Stock Information
- Founded
- EML 1858
- ME 2006
- Country
- EML United States
- ME United States
- Employees
- EML N/A
- ME N/A
- Industry
- EML Industrial Machinery/Components
- ME Precision Instruments
- Sector
- EML Consumer Discretionary
- ME Health Care
- Exchange
- EML Nasdaq
- ME Nasdaq
- Market Cap
- EML 191.3M
- ME 98.7M
- IPO Year
- EML N/A
- ME N/A
- Fundamental
- Price
- EML $26.66
- ME $3.39
- Analyst Decision
- EML
- ME Hold
- Analyst Count
- EML 0
- ME 1
- Target Price
- EML N/A
- ME $9.40
- AVG Volume (30 Days)
- EML 11.4K
- ME 219.4K
- Earning Date
- EML 11-01-2024
- ME 02-05-2025
- Dividend Yield
- EML 1.66%
- ME N/A
- EPS Growth
- EML N/A
- ME N/A
- EPS
- EML N/A
- ME N/A
- Revenue
- EML $284,461,286.00
- ME $193,260,000.00
- Revenue This Year
- EML N/A
- ME $21.93
- Revenue Next Year
- EML N/A
- ME $17.31
- P/E Ratio
- EML $13.23
- ME N/A
- Revenue Growth
- EML 7.70
- ME N/A
- 52 Week Low
- EML $22.63
- ME $2.66
- 52 Week High
- EML $35.78
- ME $16.52
- Technical
- Relative Strength Index (RSI)
- EML 43.93
- ME 44.56
- Support Level
- EML $25.31
- ME $3.15
- Resistance Level
- EML $26.90
- ME $4.18
- Average True Range (ATR)
- EML 0.69
- ME 0.26
- MACD
- EML 0.00
- ME 0.05
- Stochastic Oscillator
- EML 54.66
- ME 29.46
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.